MBX Biosciences Inc. Comm...

NASDAQ: MBX · Real-Time Price · USD
14.74
1.53 (11.58%)
At close: Aug 15, 2025, 3:59 PM
14.92
1.22%
After-hours: Aug 15, 2025, 07:58 PM EDT

MBX Biosciences Common Stock Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023
Revenue
n/a n/a 222K n/a n/a n/a n/a n/a n/a
Cost of Revenue
100K 77K n/a 100K 63K 48K n/a 100K 39K
Gross Profit
-100K -77K 111K -100K -63K -48K n/a -100K -39K
Operating Income
-21.8M -26.53M -18.61M -19.61M -16.66M -13.31M -9.99M -10.95M -8.01M
Interest Income
2.39M 2.65M 3.02M 1.47M 801K 977K 1.15M 783K 399K
Pretax Income
-19.41M -23.88M -15.59M -18.14M -15.86M -12.34M -8.84M -10.16M -7.61M
Net Income
-19.41M -23.88M -15.59M -18.14M -15.86M -12.34M -8.84M -10.16M -7.61M
Selling & General & Admin
4.08M 4.12M 3.39M 2.87M 2.2M 2.22M 2.26M 1.87M 1.49M
Research & Development
17.72M 22.41M 15.22M 16.75M 14.4M 11.05M 7.73M 9.07M 6.47M
Other Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a
Operating Expenses
21.8M 26.53M 18.61M 19.61M 16.59M 13.27M 9.99M 10.95M 7.97M
Interest Expense
n/a n/a n/a n/a n/a n/a n/a n/a n/a
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
21.8M 26.53M 18.61M 19.61M -16.66M -13.31M 9.99M 10.95M -8.01M
Income Tax Expense
n/a n/a n/a n/a n/a n/a n/a n/a n/a
Shares Outstanding (Basic)
33.45M 33.41M 33.39M 33.39M 33.38M 33.38M 31.85M 31.85M 33.38M
Shares Outstanding (Diluted)
33.45M 33.41M 33.39M 33.39M 33.38M 33.38M 31.85M 31.85M 33.38M
EPS (Basic)
-0.58 -0.71 -0.47 -0.54 -0.48 -0.37 -0.28 -0.32 -0.23
EPS (Diluted)
-0.58 -0.71 -0.47 -0.54 -0.48 -0.37 -0.28 -0.32 -0.23
EBITDA
-21.8M -26.53M -20.33M -19.54M -15.79M -12.29M -7.2M -10.9M -7.57M
EBIT
-19.41M -23.88M -20.39M -19.61M -15.86M -12.34M -7.24M -10.95M -7.61M
Depreciation & Amortization
n/a 77K 58K 75K 63K 48K 41K 40K 39K